Steven H. Holtzman, Director at INFINITY PHARMACEUTICALS, INC. (INFI), sold 215,261 shares at $13.00 ($2.6M) on 2012-05-30, disclosed to the SEC on 2012-05-31.
Open-market sale of $2.6M INFI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,000 | $0 | 0.0% |
| 2 | $13.00 | 189,303 | $2.5M | 94.5% |
| 3 | $13.00 | 10,958 | $142K | 5.5% |
| Total | $12.09 avg | 215,261 | $2.6M | 100% |
| Filing → |
| BIIB | SELL | 2014-11-12 | $578K | — | Filing → |
| BIIB | SELL | 2014-10-02 | $579K | — | Filing → |
| BIIB | SELL | 2014-05-20 | $353K | — | Filing → |